FCM
LLY icon

Fieldview Capital Management’s Eli Lilly LLY Stock Holding History

Fieldview Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-343
Closed -$267K – 472
2025
Q2 		$267K Buy
+343
New +$267K 0.04% 299

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fieldview Capital Management's LLY Position: Q3 2025 in Review

Fieldview Capital Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 343 shares — an estimated $267K sold.

Fieldview Capital Management first reported a position in LLY in Q2 2025 and held it in 1 quarter. The position peaked at $267K in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Fieldview Capital Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 343 Eli Lilly shares in Q3 2025, an estimated $267K.
  • Fieldview Capital Management first reported a position in Eli Lilly in Q2 2025 and held it in 1 quarter.
  • Fieldview Capital Management's Eli Lilly position peaked at $267K in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Fieldview Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.